Goals
Overarching Goals
- Genovis will increase knowledge about biological processes that enable new and effective treatments and medicines.
- Genovis will establish its products as the solution of choice in all analyses, from early discovery to production of tomorrow’s medications.
- Genovis will create long-term shareholder value through results that generate both dividends for shareholders and funding for the continued innovative development of the Company.
Goals 2022
Financial Targets
- Positive EBITDA.
- Genovis will achieve annual organic sales growth of at least 25 percent.
Operational Objectives
- Genovis will launch at least three products in 2022.
- Establish Genovis products as quality control tools throughout the customer's value chain from discovery to drug production.
- Establish sales in new application areas and geographic markets.